Overview Fundamentals API Earnings EOD API Sample Code Pricing

Syndax Pharmaceuticals Inc (SNDX NASDAQ) stock market data APIs

$18.82 0.01(0.1%) as of September 10, 2024
Price chart is built with Anychart

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are revumenib, a potent, selective, small molecule inhibitor of the menin-MLL binding interaction for the treatment of KMT2A rearranged, acute leukemias, and solid tumor; and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD) and idiopathic pulmonary fibrosis (IPF). The company is also developing Entinostat. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.

Syndax Pharmaceuticals Inc Financial Data Overview

18.81
18.82
-
19.19
18.6
11.215-25.34
1 600 M
85 096 K
3 500 K
-0.8
0.911
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'SNDX',
Type: 'Common Stock',
Name: 'Syndax Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000R33JY1',
ISIN: NULL,
CUSIP: NULL,
CIK: '1395937',
EmployerIdNumber: '32-0162505',
FiscalYearEnd: 'December',
IPODate: '2016-03-03',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Syndax Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 3 500 K
  • EBITDA -287 977 984
  • Earnings Per Share -3.4
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Syndax Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-08-01
  • EPS/Forecast -0.91

Get Syndax Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com